Antibacterial Tactics Based on Presepsin Level in Thoracic Aorta Surgery Patients
Recruiting
N/A
Interventional Study
Aortic Aneurysm and Dissection
Cardiac Valve Disease
Thoracic Aortic Aneurysm
Thoracic Aortic Dissection
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 75
- Sex
- Any
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 50 (estimated)
- Sponsor
- Petrovsky National Research Centre of Surgery · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
According to the literature, presepsin was recommended not only as an effective indicator in the diagnosis of sepsis in intensive care units, but also as a reliable prognostic marker of postoperative inflammatory processes in cardiac surgery. Previous study carried out in Petrovsky NRCS related to biomarkers in cardiac surgery and presepsin in particular showed good sensitivity in infection compli…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
Thoracic aorta aneurysm/dissection
Exclusion Criteria:
Blood sample hemolysis
Contacts